(C) memetis 2017 foil-based shape memory alloy deviceFoil-based SMA actuators for microfluidics
in automotive, aviation, or medical industries

memetis develops foil-based miniature actuators from shape memory alloys (SMA). These SMA Miniature actuators are used in a variety of industries. In automotive, testing equipment manufacturing and aerospace as well as medical technology and bio analytics.

Foil-based SMA miniature actuators enable high switching forces with better integration capacities and greater flexibility compared to available, wire-based solutions. They work with high forces in a small space – even the smallest actuators achieve performance characteristics of conventional actuators, which have dimensions that are a factor of 2-5

Low switching times
Extremely thin foils, and a l arge surface-to-volume ratio which achieve very low switching times.

Customizable designs
The simple and stable designs adaptable to specific market and customer requirements, even complex structures, such as multi-dimensional actuators are offered.

Competitive manufacturing
The novel memetis process and selected materials allow the manufacturing of competitive SMA miniature actuators.

Biocompatible & low fatigue
The materials used are suitable for use in medical technology or biotechnology. If requirements are particularly stringent, low fatigue materials with significantly increased operating times (>10 million switching cycles) can be used.

Silent operation
Shape memory alloys actuators enable silent operation. This allows its usage in application fields that are characterized by increased noise sensitivity.

Source: memetis GmbH 

Back to section

Related Editorial Articles

B2Bioworld offers you background information

Seiko Epson and its Business Perspectives
Minoru Usui, CEO of the Japanese electronics, printers and robotics company. Includes an independent assessment of Seiko Epson’s strategy and European assets

Laboratory Automation: Everyone Re-invents the Wheel
Michael Collasius, Vice President Automated Systems Qiagen NV on industry-wide standards for laboratory instruments

Physics <> Information <> Biology
A view from quantum optics. Interview with Alain Aspect, Professor of Physics at Institut d’Optique and Balzan Prize winner on a core concept in science, interface with biology, and felicity conditions of pluridisciplinary dialogue

Diagnostic Microfluidics: Sample In – Results Out?
Marc Feiglin, at the time Chief Technology Officer Life Sciences at Tecan (now at Merck Israel) on strengths and weaknesses of electrowetting, weaknesses of competitors like Illumina, and prospects of clinical microfluidics

Disclaimer: You agree that B2Bioworld is not responsible and will not be held liable for any third party content on its sites or any third-party content, products or services available on other web sites accessed through links from B2Bioworld sites. Links to third-party sites are for your convenience only. Their inclusion on B2Bioworld's sites does not imply any endorsement, guarantee, warranty or representation by B2Bioworld.